
Camurus
538
SEK
-13.44 %
Less than 1K followers
CAMX
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
-13.44%
-4.27%
-9.43%
-4.86%
-11.59%
-4.27%
+200.56%
+327.66%
+790.35%
Camurus operates in biotechnology. The company runs as a research-based pharmaceutical company and develops and distributes products for the treatment of severe and chronic diseases. Diseases treated with the company's products include, for example, cancer, endocrine disorders, and patients with opioid dependence. Camurus runs development projects under its own auspices and in partnership with international pharmaceutical companies. The company is headquartered in Lund.
Read moreMarket cap
31.68B SEK
Turnover
327.26M SEK
Revenue
1.87B
EBIT %
25.12 %
P/E
72.8
Dividend yield-%
-
Financial calendar
15.5
2025
Interim report Q1'25
27.5
2025
General meeting '25
17.7
2025
Interim report Q2'25
All
Webcasts
Press releases
ShowingAll content types

Camurus AB: Camurus' Interim Report January-March 2025
Camurus AB: Camurus appoints Anders Vadsholt as Chief Financial Officer
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Camurus AB: Camurus Annual Report for 2024
Camurus AB: CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU
Redeye: Camurus - A Swedish Biotech Success Story
Notice of annual general meeting 2025 in Camurus AB (publ)
Camurus AB: Camurus' CEO Fredrik Tiberg receives The Arthur D. Little Nordic Life Science Award
Camurus AB: Jon Garay Alonso will leave position as Camurus' CFO

Camurus, Audiocast with teleconference, Q4'24
Camurus AB: Camurus' Full Year Report 2024
Camurus AB: Camurus' fourth quarter and full year 2024 earnings above previous estimates
Camurus AB: Change in number of shares and votes in Camurus
Camurus AB: Camurus' Nomination Committee appointed for the Annual General Meeting 2025
Camurus AB: Camurus to present at Jefferies London Healtcare Conference
